LCDR Ramanadham is currently the Acting Director for the Division of Inspection Assessment within the Office of Pharmaceutical Quality, Office of Process and Facility (OPQ/OPF/DIA). His division is primarily responsible for the center level discipline review of facilities and inspections in support of pending drug applications. He joined the Agency in November 2009 after graduating with his Doctor of Pharmacy degree from the University of Maryland and his M.B.A. from the University of Baltimore. Prior to joining FDA, LCDR Ramanadham had experience in solid oral dosage manufacturing ranging from OTC products to schedule II narcotics. Outside of FDA, LCDR Ramanadham continues to practice pharmacy in the community setting to maintain perspective on the clinical relevancy and impact of our efforts in pharmaceutical quality.